Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5' CpG island in human tumors

Cancer Research

Volumn 59, Issue 18, 1999, Pages 4535-4541

  Toyota, Minoru ^a   Ho, Coty ^a   Ohe Toyota, Mutsumi ^a   Baylin, Stephen B ^a   Issa, Jean Pierre J ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL; COMPLEMENTARY DNA; DNA FRAGMENT;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHROMOSOME 17Q; CHROMOSOME MAP; COLON CANCER; COLON CARCINOGENESIS; CPG ISLAND; DNA DETERMINATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE INACTIVATION; GENE SEQUENCE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; METHYLATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSLATION INITIATION;

EID: 0033568534     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Antequera, F., and Bird, A. Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. USA, 90: 11995-11999, 1993.
2. Macleod, D., Ali, R. R., and Bird, A. An alternative promoter in the mouse major histocompatibility complex class II I-A β gene: implications for the origin of CpG islands. Mol. Cell. Biol., 18: 4433-4443, 1998.
3. Riggs, A. D., and Pfeifer, G. P. X-chromosome inactivation and cell memory. Trends Genet., 8: 169-174, 1992.
4. Razin, A., and Cedar, H. DNA methylation and genomic imprinting. Cell, 77: 473-476, 1994.
5. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72: 141-196, 1998.
6. Schmutte, C., and Jones, P. A. Involvement of DNA methylation in human carcinogenesis. Biol. Chem., 379: 377-388, 1998.
7. Rice, J. C., Massey-Brown, K. S., and Futscher, B. W. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene, 17: 1807-1812, 1998.
8. Kane, M. F., Loda, M., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., and Kolodner, R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res., 57: 808-811, 1997.
9. Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J-P., Markowitz, S., Willson, J. K., Hamilton, S. R., Kinzler, K. W., Kane, M. F., Kolodner, R. D., Vogelstein, B., Kunkel, T. A and Baylin, S. B. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA, 95: 6870-6875, 1998.
10. Issa, J-P., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., and Baylin, S. B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet., 7: 536-540, 1994.
11. Issa, J-P., Vertino, P. M., Boehm, C. D., Newsham, I. F., and Baylin, S. B. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc. Natl. Acad. Sci. USA, 93: 11757-11762, 1996.
12. Wales, M. M., Biel, M. A., el Deiry, W., Nelkin, B. D., Issa, J-P., Cavenee, W. K., Kuerbitz, S. J., and Baylin, S. B. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat. Med., 1: 570-577, 1995.
13. Fujii, H., Biel, M. A., Zhou, W., Weitzman, S. A., Baylin, S. B., and Gabrielson, E. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogene, 16: 2159-2164, 1998.
14. Gonzalgo, M. L., Liang, G., Spruck, C. H., III, Zingg, J. M., Rideout, W. M., III, and Jones, P. A. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res., 57: 594-599, 1997.
15. Akama, T. O., Okazaki, Y., Ito, M., Okuizumi, H., Konno, H., Muramatsu, M., Plass, C., Held, W. A., and Hayashizaki, Y. Restriction landmark genomic scanning (RLGSM)-based genome-wide scanning of mouse liver tumors for alterations in DNA methylation status. Cancer Res., 57: 3294-3299, 1997.
16. Huang, T. H., Laux, D. E., Hamlin, B. C., Tran, P., Tran, H., and Lubahn, D. B. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res. 57: 1030-1034, 1997.
17. Ushijima, T., Morimura, K., Hosoya, Y., Okonogi, H., Tatematsu, M., Sugimura, T., and Nagao, M. Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. Proc. Natl. Acad. Sci. USA, 94: 2284-2289, 1997.
18. Toyota, M., Ho, C., Ahuja, N., Jair, K-W., Li, Q., Ohe-Toyota, M., Baylin, S. B., and Issa, J-P. J. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res., 59: 2307-2312, 1999.
19. Fong, K. M. Kida, Y., Zimmerman, P. V., and Smith, P. J. Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer. Cancer Res., 55: 4268-4272, 1995.
20. Leggett, B., Young, J., Buttenshaw, R., Thomas, L., Young, B., Chenevix-Trench, G., Searle, J., and Ward, M. Colorectal carcinomas show frequent allelic loss on the long arm of chromosome 17 with evidence for a specific target region. Br. J. Cancer, 71: 1070-1073, 1995.
21. Semba, S. Yokozaki, H., and Tahara, E. Frequent microsatellile instability and loss of heterozygosity in the region including BRCA1 (17q21) in young patients with gastric cancer. Int. J. Oncol., 12: 1245-1251, 1998.
22. Gao, X., Zacharek, A., Salkowski, A., Grignon, D. J., Sakr, W., Porter, A. T., and Honn, K. V. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res., 55: 1002-1005, 1995.
23. Mori, T., Aoki, T., Matsubara, T., Iida, F., Du, X., Nishihira, T., Mori, S., and Nakamura, Y. Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus. Cancer Res., 54: 1638-1640, 1994.
24. Bockmuhl, U., Schwendel, A. Dietel, M., and Peteisen, I. Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res., 56: 5325-5329, 1996.
25. Berridge, M. J., Boolman, M. D., and Lipp, P. Calcium: a life and death signal. Nature (Lond.), 395: 645-648, 1998.
26. Perez-Reyes, E., Cribbs, L. L., Daud, A., Lacerda, A. E., Barclay, J., Williamson, M. P., Fox, M., Rees, M., and Lee, J. H. Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature (Lond.), 391: 896-900, 1998.
27. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
28. Xiong, Z., and Laird, P. W. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res., 25: 2532-2534, 1997.
29. Gardiner-Garden, M., and Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol., 196: 261-282, 1987.
30. Chen, H., Fre, S., Slepnev, V. I., Capua, M. R., Takei, K., Butler, M. H., Di Fiore, P. P., and De Camilli, P. Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis. Nature (Lond.), 394: 793-797, 1998.
31. Graff, J. R., Herman, J. G., Myohanen, S., Baylin, S. B., and Vertino, P. M. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J. Biol. Chem., 272: 22322-22329, 1997.
32. Antequera, F., Boyes, J., and Bird, A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell, 62: 503-514, 1990.
33. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., and Issa, J-P. J. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA, 96: 8681-8686, 1999.
34. 6-methylguanine-DNA methyltransferase gene. Cancer Res., 57: 3672-3677, 1997.
35. Tanaka, H., Shimada, Y., Harada, H., Shinoda, M., Hatooka, S., Imamura, M., and Ishizaki, K Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res., 58: 3429-3434, 1998.
36. Umezawa, A., Yamamoto, H., Rhodes, K., Klemsz, M. J., Maki, R. A., and Oshima, R. G. Methylation of an ETS site in the intron enhancer of the keratin 18 gene participates in tissue-specific repression. Mol. Cell. Biol., 9: 4885-4894, 1997.
37. Nan, X., Campoy, F. J., and Bird, A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88: 471-481, 1997.
38. Fern, R. Intracellular calcium and cell death during ischemia in neonatal rat white matter astrocytes in situ. J. Neurosci., 18: 7232-7243, 1998.
39. 2+ influx in cultured fibroblasts is decreased by the calcium-channel antagonist nifedipine or by some bivalent inorganic cations. Biochem. J., 295: 773-779, 1993.
40. Trump, B. F., and Berezesky, I. K. Calcium-mediated cell injury and cell death. FASEB J., 9: 219-228, 1995.
41. Murphy, A. N., Bredesen, D. E., Cortopassi, G., Wang, E., and Fiskum, G. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc. Natl. Acad. Sci. USA, 93: 9893-9898, 1996.
42. Estacion, M., and Mordan, L. J. PDGF-stimulated calcium influx changes during in vitro cell transformation. Cell. Signalling, 9: 363-366, 1997.